LataMed AI Corp. Reports Going Concern Doubt, Material Control Weakness, and New Super-Voting Preferred Stock

summarizeSummary

LataMed AI Corp. reported a going concern warning, material weakness in internal controls, zero revenue, and a new Series C super-voting preferred stock, highlighting severe financial distress and governance changes.

check_boxKey Events

• Going Concern Warning Issued

  The company reported net losses of $52,813 for the quarter and accumulated deficits of $29,653,599, raising substantial doubt about its ability to continue as a going concern. The company has no cash and a working capital deficit of $683,673.

• Material Weakness in Internal Controls

  Management concluded that financial disclosure controls and procedures were not effective due to limited internal resources and lack of multiple levels of transaction review.

• New Series C Voting Preferred Stock Authorized

  Subsequent to the quarter, the Board approved a new Series C Voting Preferred Stock with 5,000,000 authorized shares, granting 20 votes per share, which is non-convertible and has a liquidation preference senior to common stock.

• Zero Revenue and Increased Net Loss

  The company reported no revenue for the quarter ended March 31, 2026, and its net loss increased to $52,813 from $24,455 in the prior year period.

auto_awesomeAnalysis

LataMed AI Corp. faces substantial doubt about its ability to continue as a going concern, reporting zero cash, increasing net losses, and a worsening working capital deficit. The company is entirely dependent on external funding. Compounding these financial challenges, management identified a material weakness in internal controls over financial reporting. Furthermore, the Board authorized a new Series C Voting Preferred Stock with 20 votes per share, which could significantly concentrate voting power and impact corporate governance.